|1.||Sanchez-Alavez, Manuel: 1 article (12/2008)|
|2.||Frasca, Angelisa: 1 article (12/2008)|
|3.||Bartfai, Tamas: 1 article (12/2008)|
|4.||Vezzani, Annamaria: 1 article (12/2008)|
|5.||Maroso, Mattia: 1 article (12/2008)|
|6.||Ravizza, Teresa: 1 article (12/2008)|
|7.||Balosso, Silvia: 1 article (12/2008)|
|8.||Caruso, Joseph A: 1 article (12/2005)|
|9.||Mathieu, Patricia A: 1 article (12/2005)|
|10.||Reiners, John J: 1 article (12/2005)|
12/01/2005 - "Pre-treatment of 1c1c7 cultures with 3-O-MeSM also suppressed the induction of apoptosis by TNFalpha (tumour necrosis factor alpha), but offered no protection against HA14-1 [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate], staurosporine, tunicamycin or thapsigargin. "
12/01/2008 - "We show here that EEG seizures induced by intrahippocampal injection of kainic acid in C57BL6 adult mice were increased by 2-fold on average by pre-exposure to IL-1beta and this effect was blocked by 3-O-methylsphingomyelin (3-O-MS), a selective inhibitor of the ceramide-producing enzyme sphingomyelinase. "
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||ethyl 2- amino- 6- bromo- 4- (1- cyano- 2- ethoxy- 2- oxoethyl)- 4H- chromene- 3- carboxylate
|6.||Sphingomyelin Phosphodiesterase (Sphingomyelinase)
|7.||Kainic Acid (Kainate)